Tirzepatide is a novel dual-receptor agonist that targets both GLP-1 and GIP receptors. It demonstrates excellent performance in glycemic control and weight management, serving as a key ingredient for pharmaceutical research and advanced health products. Our high-purity Tirzepatide is produced under strict quality control, ensuring stable bioactivity and reliable consistency.